The Kenyan government is contemplating extending the Human Papillomavirus (HPV) vaccination programme to boys. This move aims to prevent cervical cancer and other HPV-related diseases. Medical Services Principal Secretary Ouma Oluga stated that vaccinating boys could become a crucial part of the country's long-term disease prevention strategy. The current programme focuses on girls, but low completion rates for the second dose have raised concerns.
According to the Kenya Mini Demographic and Health Survey, only 20% of girls have received the recommended second dose of the HPV vaccine. In contrast, 59% of girls have received at least one dose, an increase from 30% recorded in the 2022 survey. This significant drop between first-dose and second-dose coverage raises concerns about Kenya's ability to ensure that more girls complete the recommended vaccination schedule.
Ouma Oluga acknowledged that more efforts are needed to strengthen HPV vaccination and expand protection against the virus among young people. He mentioned that the government could consider extending the programme to boys in the future, describing it as an important area for further attention. The PS highlighted the burden of cervical cancer in Kenya, stating that the disease affects approximately 7,000 women every year.
Cervical cancer is largely caused by persistent infection with high-risk types of HPV, a common virus primarily transmitted through sexual contact. HPV vaccination before exposure to the virus offers the strongest protection against infection and related diseases. While HPV vaccination programmes have traditionally prioritised girls, vaccinating boys can also help reduce transmission and protect them against other HPV-related conditions, including certain cancers.
The latest survey figures suggest that Kenya has made progress in increasing access to the first HPV vaccine dose, with coverage rising from 30% in 2022 to 59%. However, the fact that only 20% of girls have received the second dose points to persistent challenges in follow-up, public awareness, and access to vaccination services. The government has yet to announce a timeline for the proposed intervention.
Expanding the programme to boys would require additional planning and resources. Oluga's remarks signal a possible future policy direction rather than an immediate change to the national HPV vaccination programme. The government is taking steps to address the low completion rates for the HPV vaccine among girls and prevent cervical cancer and other HPV-related diseases.
The HPV vaccination programme is crucial in preventing cervical cancer, which affects approximately 7,000 women in Kenya every year. Vaccinating boys can help reduce transmission and protect them against other HPV-related conditions. The government is expected to make a decision on extending the programme to boys in the future.
Key points
- The Kenyan government is considering extending the HPV vaccination programme to boys due to low completion rates for the second dose among girls.
- Only 20% of girls in Kenya have received the recommended second dose of the HPV vaccine.
- Cervical cancer affects approximately 7,000 women in Kenya every year, primarily caused by persistent infection with high-risk types of HPV.
